Logo image of ICAD

ICAD INC (ICAD) Stock Price, Quote, News and Overview

NASDAQ:ICAD - Nasdaq - US44934S2068 - Common Stock - Currency: USD

3.74  -0.08 (-2.09%)

After market: 3.74 0 (0%)

ICAD Quote, Performance and Key Statistics

ICAD INC

NASDAQ:ICAD (5/22/2025, 8:12:32 PM)

After market: 3.74 0 (0%)

3.74

-0.08 (-2.09%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
Statistics
52 Week High4.01
52 Week Low1.18
Market Cap102.36M
Shares27.37M
Float25.85M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-11 2025-08-11/bmo
IPO12-13 1984-12-13


ICAD short term performance overview.The bars show the price performance of ICAD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 100

ICAD long term performance overview.The bars show the price performance of ICAD in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 50 100 150

The current stock price of ICAD is 3.74 USD. In the past month the price increased by 13.33%. In the past year, price increased by 136.71%.

ICAD INC / ICAD Daily stock chart

ICAD Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
VEEV VEEVA SYSTEMS INC-CLASS A 35.63 38.32B
DOCS DOXIMITY INC-CLASS A 36.35 9.62B
WAY WAYSTAR HOLDING CORP 48.35 6.61B
CERT CERTARA INC 23.43 1.85B
SDGR SCHRODINGER INC N/A 1.56B
PHR PHREESIA INC N/A 1.43B
GDRX GOODRX HOLDINGS INC-CLASS A 11.24 1.37B
TDOC TELADOC HEALTH INC N/A 1.21B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A 1.09B
EVH EVOLENT HEALTH INC - A 19.37 864.06M
HSTM HEALTHSTREAM INC 44.16 849.34M
CCLDO CARECLOUD INC - CCLD 8 3/4 PERP N/A 837.94M

About ICAD

Company Profile

ICAD logo image iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. The company is headquartered in Nashua, New Hampshire and currently employs 66 full-time employees. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a two-dimensional or three-dimensional mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting and algorithmically examining.

Company Info

ICAD INC

98 Spit Brook Rd Ste 100

Nashua NEW HAMPSHIRE 03062 US

CEO: Michael Klein

Employees: 66

ICAD Company Website

ICAD Investor Relations

Phone: 16038825200

ICAD INC / ICAD FAQ

What is the stock price of ICAD INC today?

The current stock price of ICAD is 3.74 USD. The price decreased by -2.09% in the last trading session.


What is the ticker symbol for ICAD INC stock?

The exchange symbol of ICAD INC is ICAD and it is listed on the Nasdaq exchange.


On which exchange is ICAD stock listed?

ICAD stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ICAD INC stock?

10 analysts have analysed ICAD and the average price target is 3.57 USD. This implies a price decrease of -4.55% is expected in the next year compared to the current price of 3.74. Check the ICAD INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ICAD INC worth?

ICAD INC (ICAD) has a market capitalization of 102.36M USD. This makes ICAD a Micro Cap stock.


How many employees does ICAD INC have?

ICAD INC (ICAD) currently has 66 employees.


What are the support and resistance levels for ICAD INC (ICAD) stock?

ICAD INC (ICAD) has a support level at 3.73 and a resistance level at 4. Check the full technical report for a detailed analysis of ICAD support and resistance levels.


Is ICAD INC (ICAD) expected to grow?

The Revenue of ICAD INC (ICAD) is expected to grow by 4.71% in the next year. Check the estimates tab for more information on the ICAD EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ICAD INC (ICAD) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ICAD INC (ICAD) stock pay dividends?

ICAD does not pay a dividend.


When does ICAD INC (ICAD) report earnings?

ICAD INC (ICAD) will report earnings on 2025-08-11, before the market open.


What is the Price/Earnings (PE) ratio of ICAD INC (ICAD)?

ICAD INC (ICAD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.18).


What is the Short Interest ratio of ICAD INC (ICAD) stock?

The outstanding short interest for ICAD INC (ICAD) is 1.2% of its float. Check the ownership tab for more information on the ICAD short interest.


ICAD Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to ICAD. When comparing the yearly performance of all stocks, ICAD is one of the better performing stocks in the market, outperforming 97.78% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ICAD Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ICAD. While ICAD has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ICAD Financial Highlights

Over the last trailing twelve months ICAD reported a non-GAAP Earnings per Share(EPS) of -0.18. The EPS decreased by -50% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -14.96%
ROE -19.58%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%60%
Sales Q2Q%-1.61%
EPS 1Y (TTM)-50%
Revenue 1Y (TTM)13.22%

ICAD Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 76% to ICAD. The Buy consensus is the average rating of analysts ratings from 10 analysts.

For the next year, analysts expect an EPS growth of 5.29% and a revenue growth 4.71% for ICAD


Ownership
Inst Owners23.48%
Ins Owners5.63%
Short Float %1.2%
Short Ratio0.34
Analysts
Analysts76
Price Target3.57 (-4.55%)
EPS Next Y5.29%
Revenue Next Year4.71%